We are live on ! Find out more
CANF

Can-Fite BioPharma American Depositary Shares
CANF

13 hedge funds and large institutions have $472K invested in Can-Fite BioPharma American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

13% less funds holding

Funds holding: 15 → 13 (-2)

25% less capital invested

Capital invested by funds: $626K → $472K (-$154K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$76K
2
Citadel Advisors
Citadel Advisors
Florida
+$13.2K
3
UBS Group
UBS Group
Switzerland
+$8.31K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$1.85K

Top Sellers

Rank Fund Capital Flow
1
CAN
Cetera Advisor Networks
California
-$169K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$36K
3
TSS
Two Sigma Securities
New York
-$23K
4
HF
HRT Financial
New York
-$15K
5
Osaic Holdings
Osaic Holdings
Arizona
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$377K +$76K +329 +28%
Fifth Third Bancorp
2
Fifth Third Bancorp
Ohio
$37K – – –
Stifel Financial
3
Stifel Financial
Missouri
$15K – – –
Citadel Advisors
4
Citadel Advisors
Florida
$14K +$13.2K +57 New
UBS Group
5
UBS Group
Switzerland
$9K +$8.31K +36 New
Citigroup
6
Citigroup
New York
$7K – – –
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$7K – – –
Wells Fargo
8
Wells Fargo
California
$2K – – –
CAPTRUST Financial Advisors
9
CAPTRUST Financial Advisors
North Carolina
$2K +$1.85K +8 New
APA
10
American Portfolios Advisors
New York
$1.36K – – –
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$661 – – –
TWC
12
TD Waterhouse Canada
Ontario, Canada
$303 – – –
CAN
13
Cetera Advisor Networks
California
– -$169K -654 Closed
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
– -$36K -143 Closed
TSS
15
Two Sigma Securities
New York
– -$23K -89 Closed
HF
16
HRT Financial
New York
– -$15K -60 Closed
Osaic Holdings
17
Osaic Holdings
Arizona
– -$1K -6 Closed

CANF Hedge Fund Activity: Q1 2022 in Review

13 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2022, worth a combined $472K — down 25% from $626K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CANF and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $76K. The largest seller was Cetera Advisor Networks, exiting entirely with an estimated $169K sold.

  • 13 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2022, down from 15 in Q4 2021.
  • Funds reported $472K of Can-Fite BioPharma American Depositary Shares stock for Q1 2022, down 25% quarter-over-quarter.
  • 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2022 was Morgan Stanley, an estimated $76K added.
  • The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2022 was Cetera Advisor Networks, an estimated $169K sold.

Based on aggregated 13F filings for Q1 2022.